Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004657307 | SCV005153332 | uncertain significance | Inborn genetic diseases | 2024-06-03 | criteria provided, single submitter | clinical testing | The c.10918G>A (p.A3640T) alteration is located in exon 37 (coding exon 37) of the PKD1 gene. This alteration results from a G to A substitution at nucleotide position 10918, causing the alanine (A) at amino acid position 3640 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV005015224 | SCV005640963 | uncertain significance | Polycystic kidney disease, adult type | 2024-05-30 | criteria provided, single submitter | clinical testing | |
Department of Pathology and Laboratory Medicine, |
RCV005015224 | SCV006058174 | uncertain significance | Polycystic kidney disease, adult type | 2024-11-29 | criteria provided, single submitter | clinical testing |